Vinva Investment Management Ltd Has $12.21 Million Stock Holdings in Veeva Systems Inc. $VEEV

Key Points

• Vinva Investment Management increased its stake in Veeva Systems by 19.4% in Q3 to 41,661 shares, valued at about $12.21 million.
• Veeva beat Q4 expectations with $2.06 EPS (vs. $1.94 consensus) and $835.95M revenue (+16% YoY), and management flagged AI initiatives and CRM expansion as key growth drivers.
• The board approved a $2.00 billion share buyback (up to 5.5% of shares), indicating management views the stock as undervalued.

Vinva Investment Management Ltd boosted its stake in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 19.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 41,661 shares of the technology company's stock after purchasing an additional 6,763 shares during the period. Vinva Investment Management Ltd's holdings in Veeva Systems were worth $12,207,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. GPS Wealth Strategies Group LLC grew its stake in shares of Veeva Systems by 196.4% during the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company's stock worth $25,000 after buying an additional 55 shares during the last quarter. Raiffeisen Bank International AG bought a new position in shares of Veeva Systems in the 3rd quarter valued at $28,000. OLD Second National Bank of Aurora bought a new position in shares of Veeva Systems in the 3rd quarter valued at $30,000. Legacy Investment Solutions LLC acquired a new stake in shares of Veeva Systems during the 2nd quarter valued at $32,000. Finally, Cary Street Partners Investment Advisory LLC boosted its holdings in shares of Veeva Systems by 58.3% during the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company's stock valued at $38,000 after acquiring an additional 49 shares in the last quarter. Institutional investors and hedge funds own 88.20% of the company's stock.

Veeva Systems Price Performance

Shares of VEEV opened at $195.89 on Friday. The business has a 50-day moving average of $203.47 and a 200-day moving average of $247.17. The company has a market capitalization of $32.20 billion, a price-to-earnings ratio of 36.21, a price-to-earnings-growth ratio of 1.35 and a beta of 1.09. Veeva Systems Inc. has a 1 year low of $168.13 and a 1 year high of $310.50.

Veeva Systems (NYSE:VEEV - Get Free Report) last announced its earnings results on Wednesday, March 4th. The technology company reported $2.06 EPS for the quarter, beating the consensus estimate of $1.94 by $0.12. The business had revenue of $835.95 million for the quarter, compared to analysts' expectations of $810.95 million. Veeva Systems had a return on equity of 14.11% and a net margin of 28.44%.The firm's revenue was up 16.0% on a year-over-year basis. During the same period in the prior year, the business posted $1.74 earnings per share. Veeva Systems has set its FY 2027 guidance at 8.850- EPS and its Q1 2027 guidance at 2.130-2.14 EPS. As a group, sell-side analysts anticipate that Veeva Systems Inc. will post 4.35 EPS for the current year.

Veeva Systems announced that its Board of Directors has approved a share buyback plan on Monday, January 5th that permits the company to buyback $2.00 billion in outstanding shares. This buyback authorization permits the technology company to buy up to 5.5% of its shares through open market purchases. Shares buyback plans are typically a sign that the company's management believes its stock is undervalued.

Veeva Systems News Roundup

Here are the key news stories impacting Veeva Systems this week:

• Positive Sentiment: Q4 beats and raised outlook — Veeva reported revenue of ~$836M (+16% y/y) and non‑GAAP EPS of $2.06, above consensus, and provided FY27 guidance that came in ahead of some estimates, which drove the initial rally. Article Title
• Positive Sentiment: AI and product roadmap cited as growth drivers — Management emphasized “agentic” AI initiatives and CRM expansion (CRM targeted to be ~10% of revenue by 2030), positioning Veeva to capture higher‑value services and offset broader software AI fears. Article Title
• Positive Sentiment: Analyst support and buy ratings remain — Several firms reaffirmed or raised ratings/targets (e.g., Stifel raised target to $245; Truist reaffirmed buy), keeping institutional sentiment constructive despite some cuts. Article Title
• Neutral Sentiment: Earnings call detail available for deeper read — The full Q4 earnings call/transcript provides color on customer uptake, AI timing and margin outlook; useful for investors who want to judge execution risk vs opportunity. Article Title
• Neutral Sentiment: Technical/volume context — Trading volume was a bit below average and the stock remains under its 50‑ and 200‑day moving averages, which can limit near‑term upside until momentum recovers. (See market data summary above.)
• Negative Sentiment: Price‑target cuts and cautious notes — Multiple firms trimmed price targets (Canaccord, Piper Sandler, Needham, RBC, Wells Fargo among others) citing decelerating growth, margin pressure or to reflect model changes—these headlines trimmed upside and likely capped the post‑earnings rally. Article Title
• Negative Sentiment: Ongoing AI disruption debate — Despite Veeva’s positioning, some investors remain worried about how AI will change software economics and competitive dynamics; a few analysts argue AI risk and growth normalization justify a more cautious stance. Article Title

Insider Activity

In other news, insider Thomas D. Schwenger sold 1,000 shares of the business's stock in a transaction that occurred on Tuesday, January 13th. The shares were sold at an average price of $231.43, for a total value of $231,430.00. Following the transaction, the insider owned 23,204 shares in the company, valued at approximately $5,370,101.72. The trade was a 4.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 10.30% of the company's stock.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on VEEV. Wells Fargo & Company lowered their target price on Veeva Systems from $333.00 to $317.00 and set an "overweight" rating for the company in a report on Thursday. Weiss Ratings lowered Veeva Systems from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Monday, January 12th. Canaccord Genuity Group reduced their price target on Veeva Systems from $280.00 to $235.00 and set a "hold" rating on the stock in a report on Thursday. Piper Sandler lowered their price objective on Veeva Systems from $355.00 to $285.00 and set an "overweight" rating for the company in a research note on Thursday. Finally, Robert W. Baird raised their price objective on shares of Veeva Systems from $314.00 to $319.00 and gave the company an "outperform" rating in a report on Friday, November 21st. Seventeen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $284.91.

About Veeva Systems

Veeva Systems NYSE: VEEV is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva's product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.